INVESTOR RELATIONS

CORPORATE OVERVIEW

Immunome is a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome’s proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease.

LATEST PRESENTATION

06/09/2022

Immunome Corporate Presentation

Harnessing the Power of the Human Memory B Cell

LATEST EVENTS

09/29/2021 08:40 AM ET

Cantor Global Healthcare Conference

09/29/2021 08:40 AM ET

Cantor Global Healthcare Conference

Menu